• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Novanta Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities

    6/9/25 4:30:36 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous
    Get the next $NOVT alert in real time by email
    8-K
    0001076930false00010769302025-06-032025-06-03

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    FORM 8-K

    CURRENT REPORT

    Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): June 3, 2025

    NOVANTA INC.

    (Exact name of registrant as specified in is charter)

    New Brunswick, Canada

    001-35083

    98-0110412

    (State or other jurisdiction

    of incorporation)

    (Commission File Number)

    (IRS Employer

    Identification No.)

     

     

     

    125 Middlesex Turnpike

    Bedford, Massachusetts

    01730

    (Address of principal executive offices)

    (Zip Code)

    Registrant’s telephone number, including area code: (781) 266-5700

    Not Applicable

    (Former name or former address, if changed since last report)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading

    Symbol(s)

     

    Name of each exchange on which registered

    Common shares, no par value

     

    NOVT

     

    Nasdaq Global Select Market

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


     

    Item 2.05 Costs Associated with Exit or Disposal Activities

    On June 3, 2025, Novanta Inc. (the “Company”) committed to a restructuring plan (the “2025 Restructuring Plan”) to streamline operations and align with long-term goals. The 2025 Restructuring Plan includes measures to regionalize manufacturing operations, expedite the closure of certain sites, streamline management structures, and implement cost-saving strategies in areas anticipated to have a minimal long-term impact on the Company's overall business performance.

    The Company estimates that it will incur approximately $20 million to $25 million in pre-tax charges in connection with the 2025 Restructuring Plan, consisting of employee-related costs, third-party manufacturing moving costs, contract terminations, asset write-offs and other costs. The 2025 Restructuring Plan will commence in June 2025 and is anticipated to be substantially completed within an estimated eighteen-month period. The Company expects savings from this initiative of approximately $20 million on an annualized basis once the 2025 Restructuring Plan is completed.

    The estimates of costs and expenses that the Company expects to incur in connection with the 2025 Restructuring Plan are subject to several assumptions and actual results may differ materially. The Company may also incur additional costs not currently contemplated due to events that may occur because of, or that are associated with, the 2025 Restructuring Plan.

    Safe Harbor and Forward-Looking Information

    This Current Report on Form 8-K contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and are based on current expectations and assumptions that are subject to risks and uncertainties. All statements contained in this 8-k that do not relate to matters of historical fact should be considered forward-looking statements, and are generally identified by words such as “estimate,” “expect,” “believe,” “future,” “could,” “should,” “plan,” “aim,” and other similar expressions and include, without limitation, statements regarding the Company’s restructuring plan, its expectations and estimates regarding the workforce reduction, the objectives of the restructuring plan and the timing thereof, amounts and timing of the charges, savings to be incurred in connection with the restructuring plan, and the potential impact of the restructuring plan. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. Potential risks and uncertainties that could cause actual results to differ from expected results include, among others, whether the Company will be able to implement the restructuring program as planned, whether additional measures outside those set forth herein will need to be taken to fulfill the objectives of the restructuring plan, whether the expected amount of the costs associated with the restructuring program will differ from or exceed the Company's forecasts and whether the Company will be able to realize the full amount of estimated savings from the restructuring program or in the timeframe expected. It is not possible to predict or identify all risks and uncertainties, and additional significant risks and uncertainties are described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, and subsequent reports filed with the Securities and Exchange Commission. The reader should not place undue reliance on forward-looking statements, which speak only as of the date they are first made. Except to the extent required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events.

     


     

    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

     

    Novanta Inc.

    Date: June 9, 2025

    By:

    /s/ Robert J. Buckley

    Robert J. Buckley

    Chief Financial Officer

     

     

     

     


    Get the next $NOVT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NOVT

    DatePrice TargetRatingAnalyst
    5/11/2022Mkt Perform → Outperform
    William Blair
    More analyst ratings

    $NOVT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Novanta Inc. Announces Pricing of $550,000,000 Tangible Equity Units Offering

    Novanta Inc. (NASDAQ:NOVT) ("Novanta" or the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that it has priced its previously announced public offering of 11 million of its 6.50% tangible equity units at $50.00 per unit (equal to the stated amount per unit). The transaction is a public offering made by means of a prospectus supplement under Novanta's effective shelf registration statement. Novanta's common shares are quoted on Nasdaq under the ticker symbol "NOVT," and Novanta has applied to list the tangible equity units on Nasdaq under the symbol "NOVTU." Novanta anticipates that the offering will close on November 12,

    11/7/25 7:15:00 AM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    Novanta Inc. Announces Offering of Tangible Equity Units

    Novanta Inc. (NASDAQ:NOVT) ("Novanta" or the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that it has commenced a public offering of 11 million tangible equity units, with an aggregate stated amount of $550.0 million. Each tangible equity unit will have a stated amount of $50.00 and be comprised of a prepaid stock purchase contract and a senior amortizing note due 2028, each issued by Novanta. The tangible equity unit offering is a public offering made by means of a prospectus supplement under Novanta's effective shelf registration statement. Novanta's common shares are quoted on Nasdaq under the ticker symbol "NOVT," a

    11/5/25 4:12:00 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    Novanta Announces Financial Results for the Third Quarter 2025

    Third Quarter 2025 GAAP Revenue increased 1.4% to $247.8 million Third Quarter 2025 GAAP Net Income of $10.7 million Third Quarter 2025 GAAP Diluted Earnings Per Share of $0.30 Third Quarter 2025 Adjusted EBITDA of $58.1 million Third Quarter 2025 Adjusted EPS of $0.87 Novanta Inc. (NASDAQ:NOVT) ("Novanta" or the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the third quarter 2025. Financial Highlights Three Months Ended (In millions, except per share amounts) September 26,   September 27,   2025   2024 GAAP  

    11/3/25 5:00:00 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    $NOVT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Manganiello Alexander

    3 - NOVANTA INC (0001076930) (Issuer)

    12/5/25 4:15:29 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    Chief Executive Officer Glastra Matthijs gifted 15,693 shares and received a gift of 15,693 shares, increasing direct ownership by 23% to 85,367 units (SEC Form 4)

    4 - NOVANTA INC (0001076930) (Issuer)

    12/2/25 4:49:08 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    SEC Form 4 filed by Director Farrell Matthew

    4 - NOVANTA INC (0001076930) (Issuer)

    11/5/25 4:52:18 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    $NOVT
    SEC Filings

    View All

    Novanta Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - NOVANTA INC (0001076930) (Filer)

    12/1/25 4:30:27 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    Amendment: SEC Form SCHEDULE 13G/A filed by Novanta Inc.

    SCHEDULE 13G/A - NOVANTA INC (0001076930) (Subject)

    11/14/25 12:19:22 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    Novanta Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - NOVANTA INC (0001076930) (Filer)

    11/13/25 4:46:46 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    $NOVT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Novanta upgraded by William Blair

    William Blair upgraded Novanta from Mkt Perform to Outperform

    5/11/22 6:19:56 AM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    $NOVT
    Financials

    Live finance-specific insights

    View All

    Novanta Announces Financial Results for the Third Quarter 2025

    Third Quarter 2025 GAAP Revenue increased 1.4% to $247.8 million Third Quarter 2025 GAAP Net Income of $10.7 million Third Quarter 2025 GAAP Diluted Earnings Per Share of $0.30 Third Quarter 2025 Adjusted EBITDA of $58.1 million Third Quarter 2025 Adjusted EPS of $0.87 Novanta Inc. (NASDAQ:NOVT) ("Novanta" or the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the third quarter 2025. Financial Highlights Three Months Ended (In millions, except per share amounts) September 26,   September 27,   2025   2024 GAAP  

    11/3/25 5:00:00 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 4, 2025

    Novanta Inc. (NASDAQ:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2025 results on Tuesday, November 4, 2025. The Company will host a conference call on Tuesday, November 4, 2025, at 8:30 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed online via a live webcast on the Events & Presentations page of the Investors section of the Company's website at www.novanta.com. A replay of the audio webcast will be available approximately three hours after the conclusion of the ca

    10/7/25 5:00:00 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    Novanta Announces Financial Results for the Second Quarter 2025

    Second Quarter 2025 GAAP Revenue increased 2% to $241 million Second Quarter 2025 GAAP Net Income of $4.5 million Second Quarter 2025 GAAP Diluted Earnings Per Share of $0.12 Second Quarter 2025 Adjusted EBITDA of $52 million Second Quarter 2025 Adjusted EPS of $0.76 Company updates Full Year 2025 financial guidance Novanta Inc. (NASDAQ:NOVT) ("Novanta" or the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the second quarter 2025. Financial Highlights Three Months Ended   (In millions, except per share amounts) June 27,     June 28,

    8/5/25 6:55:00 AM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    $NOVT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Novanta Inc.

    SC 13G/A - NOVANTA INC (0001076930) (Subject)

    11/14/24 1:22:36 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    SEC Form SC 13G filed by Novanta Inc.

    SC 13G - NOVANTA INC (0001076930) (Subject)

    2/14/24 10:02:59 AM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    SEC Form SC 13G/A filed by Novanta Inc. (Amendment)

    SC 13G/A - NOVANTA INC (0001076930) (Subject)

    2/13/24 5:09:44 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    $NOVT
    Leadership Updates

    Live Leadership Updates

    View All

    IDEX Corporation Appoints Stephanie Disher and Matthijs Glastra to Board of Directors; David Parry and Livingston Satterthwaite to Retire

    IDEX Corporation (NYSE:IEX) today announced the appointment of Stephanie ("Steph") Disher and Matthijs Glastra to the company's Board of Directors. The appointments, effective Friday, February 21, 2025, increase the size of the Board from 10 to 12 directors. Ms. Disher will serve on the Board's Nominating and Corporate Governance Committee, and Mr. Glastra will serve on the Board's Audit Committee. Ms. Disher currently serves as Chief Executive Officer of Atmus Filtration Technologies Inc. (NYSE:ATMU), a leader in filtration and media solutions. She has extensive global leadership experience in finance and operations from her time at Atmus, Cummins Inc. and BP, p.l.c. Mr. Glastra currentl

    2/20/25 5:07:00 PM ET
    $ATMU
    $IEX
    $NOVT
    Auto Parts:O.E.M.
    Consumer Discretionary
    Fluid Controls
    Industrials

    Politan Details Why a Truly Independent Board is Urgently Needed at Masimo in Order to Protect Shareholder Value and Realize the Company's Full Potential

    Sends Letter to Masimo Shareholders and Releases 160-Page Investor Presentation Urges Shareholders to Help Deliver Immediate Change by Voting for Both of Politan's Independent and Ideally Qualified Nominees Darlene Solomon and William Jellison on the WHITE Card Shareholders Can Visit www.AdvanceMasimo.com for Further Information Politan Capital Management (together with its affiliates, "Politan"), an 8.9% shareholder of Masimo Corporation ("Masimo" or the "Company") (NASDAQ:MASI), today sent a letter to the Company's shareholders outlining why a majority of truly independent directors are urgently needed in the Masimo boardroom. Politan also released a detailed investor presentation m

    6/26/24 8:00:00 AM ET
    $A
    $ANIK
    $AVNT
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Medical/Dental Instruments
    Health Care